[1]
Gabriel, F.V.K. et al. 2026. USE OF DUAL AND TRIPLE INCRETIN AGONISTS (TIRZEPATIDE AND RETATRUTIDE) IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS . Seven Editora. (Apr. 2026), 174–183. DOI:https://doi.org/10.56238/sevened2026.020-013.